Meridian Bioscience reported $36.14M in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2912M 534M
Accelerate Diagnostics AXDX:US -13249000 6.21M
Atrion ATRI:US 7.84M 1.64M
Becton, Dickinson and BDX:US $ 652M 163M
Bio Rad Laboratories BIO:US $ 143.42M 36.44M
Cerulean Pharma CERU:US $ -8400450 1.14M
Cerus CERS:US $ -9848000 2.89M
Meridian Bioscience VIVO:US $ 36.14M 15.86M
Myriad Genetics MYGN:US $ -25.6M 17.5M
Orasure Technologies OSUR:US $ -15.98M 6.61M
Quidel QDEL:US $ 620.66M 243.93M
Sientra SIEN:US -16095000 2.37M
Staar Surgical STAA:US $ 12.11M 4.73M
Thermo Fisher Scientific TMO:US $ 2821M 1050M
Utah Medical Products UTMD:US 5.1M 1.21M